Frequency of <i>De Novo</i> Hepatocellular Carcinoma after Direct-acting Antiviral Therapy for Chronic Hepatitis C: A Prospective Follow-up.

Euroasian J Hepatogastroenterol · 2022 · PMC10028701 · PMID 36959987

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Conclusion The risk of the development of HCC after antiviral treatment is highly significant among patients with liver cirrhosis.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.